Daratumumab (anti-CD38)

Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.

Daratumumab (anti-CD38)

Click to purchase the isotype control of Daratumumab (anti-CD38)

Selleck's Daratumumab (anti-CD38) has been cited by 2 publications

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 5.72 mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective CD markers Inhibitors

Name Citation CD38 CD45 CD39 CD88 CD73 Others
RBN013209 0
MK-0159 0
CD38 inhibitor 1 (compound 78c) 5
AB680 0
NQ301 1 TXA2 receptor
SodiuM Metatungstate 3
PMX-53
LY-3475070
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.

Product Details

CAS No. 945721-28-8
Isotype Human IgG1
Source Human
Formulation PBS Buffer, PH 7.4
Storage
(From the date of receipt)
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Daratumumab (anti-CD38) | Daratumumab (anti-CD38) supplier | purchase Daratumumab (anti-CD38) | Daratumumab (anti-CD38) cost | Daratumumab (anti-CD38) manufacturer | order Daratumumab (anti-CD38) | Daratumumab (anti-CD38) distributor